Universitätsmedizin Rostock

Cetuximab, fluorouracil and cisplatin with or without docetaxel for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (CeFCiD): an open-label phase II randomised trial (AIO/IAG-KHT trial 1108) (2019) Klinghammer K, Gauler T, Dietz A, Grünwald V, Stöhlmacher J, Knipping S, Schroeder M, et al. Journal article Impact of chronic kidney disease on efficacy and safety of interventional left atrial appendage closure - results from the prospective multicenter LAARGE registry (2019) Fastner C, Brachmann J, Lewalter T, Zeymer U, Sievert H, Nienaber CA, Weiss C, et al. Conference contribution Doping in Sport Climbing: Status Quo in a New Olympic Discipline (2019) Lutter C, Tischer T, El-Sheikh Y, Schöffl VR Journal article An integrated genome-wide multi-omics analysis of gene expression dynamics in the preimplantation mouse embryo (2019) Israel S, Ernst M, Psathaki OE, Drexler HC, Casser E, Suzuki Y, Makalowski W, et al. Journal article Nab-paclitaxel improves disease-free survival in early breast cancer: GBG 69–Geparsepto (2019) Untch M, Jackisch C, Schneeweiss A, Schmatloch S, Aktas B, Denkert C, Schem C, et al. Journal article The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Compartment Syndrome of the Foot: An Evidence-Based Review (2019) Lutter C, Schöffl VR, Hotfiel T, Simon M, Maffulli N Journal article, Review article Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study (2019) Mavratzas A, Baek S, Gerber B, Schmidt M, Moebus , Foerster F, Grischke EM, et al. Journal article Comparison of cytokine/chemokine levels in aqueous humor of primary open-angle glaucoma patients with positive or negative outcome following trabeculectomy (2019) Gajda-Deryło B, Stahnke T, Struckmann S, Warsow G, Birke K, Birke MT, Hohberger B, et al. Journal article A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA) (2019) Bischoff J, Barinoff J, Mundhenke C, Bauerschlag DO, Costa SD, Herr D, Luebbe K, et al. Journal article